New York State Common Retirement Fund Pep Gen Inc. Transaction History

New York State Common Retirement Fund

  • $74.9 Billion
  • Q3 2025

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2025
BUY
$7.75 - $18.55 $50,258 - $120,296
6,485 New
6,485 $55,000
Q2 2024

Oct 08, 2025
BUY
$10.54 - $18.14 $68,351 - $117,637
6,485 New
6,485 $103,000
Q2 2024

Jul 31, 2024
BUY
$10.54 - $18.14 $52 - $90
5 Added 0.08%
6,485 $104,000
Q1 2024

Oct 08, 2025
BUY
$6.63 - $17.3 $42,962 - $112,104
6,480 New
6,480 $95,000
Q1 2024

May 07, 2024
SELL
$6.63 - $17.3 $19 - $51
-3 Reduced 0.05%
6,480 $95,000
Q4 2023

Oct 08, 2025
BUY
$3.86 - $7.96 $25,024 - $51,604
6,483 New
6,483 $44,000
Q4 2023

Feb 01, 2024
SELL
$3.86 - $7.96 $119 - $246
-31 Reduced 0.48%
6,483 $44,000
Q3 2023

Oct 08, 2025
BUY
$5.0 - $9.09 $32,570 - $59,212
6,514 New
6,514 $33,000
Q2 2023

Oct 08, 2025
BUY
$8.94 - $16.39 $58,235 - $106,764
6,514 New
6,514 $58,000
Q2 2023

Aug 07, 2023
SELL
$8.94 - $16.39 $134 - $245
-15 Reduced 0.23%
6,514 $58,000
Q1 2023

Oct 08, 2025
SELL
$11.44 - $17.7 $19,997 - $30,939
-1,748 Reduced 21.12%
6,529 $79,000
Q1 2023

May 02, 2023
SELL
$11.44 - $17.7 $19,997 - $30,939
-1,748 Reduced 21.12%
6,529 $80,000
Q4 2022

Oct 08, 2025
BUY
$9.31 - $16.57 $77,058 - $137,149
8,277 New
8,277 $110,000
Q3 2022

Nov 08, 2022
BUY
$4.86 - $12.75 $374 - $981
77 Added 0.94%
8,277 $75,000
Q2 2022

Aug 04, 2022
BUY
$9.0 - $12.89 $73,800 - $105,698
8,200 New
8,200 $81,000

Others Institutions Holding PEPG

# of Institutions
78
Shares Held
57.1M
Call Options Held
1.14M
Put Options Held
103K
View Full List

About PepGen Inc.

PEPG Quotes by TradingView
  • Ticker PEPG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,631,900
  • Market Cap $112M
  • Description
  • PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...
More about PEPG
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email